Sep 22, 2021
Detailed results from the positive Phase II DESTINY-Gastric02 trial showed that Enhertu (trastuzumab deruxtecan), the AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) HER2-directed antibody drug conjugate (ADC), provided a...
Sep 20, 2021
Novartis recently announced positive health-related quality of life (HRQoL) data from its Phase III VISION study evaluating 177Lu-PSMA-617, an investigational targeted radioligand therapy, plus standard of care for metastatic castration-resistant prostate cancer...
Sep 17, 2021
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug pembrolizumab (Keytruda) for some adults with bowel cancer that’s spread to other parts of the body. Pembrolizumab will be made available to people with bowel...
Sep 8, 2021
NICE has published (8 September 2021) final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy (ADT) for treating prostate cancer in adults. The positive recommendations follow an improved...
Sep 1, 2021
Bowel Cancer UK is supporting a new phase of the NHS’s Help Us, Help You campaign which encourages people with potential bowel cancer symptoms to come forward for lifesaving checks. The campaign hopes to remind people that they should not feel like they cannot...
